<DOC>
	<DOCNO>NCT00519142</DOCNO>
	<brief_summary>The primary objective study demonstrate whether mitiglinide administer combination metformin effective metformin alone patient Type 2 diabetes mellitus ( T2DM ) whose blood sugar well control take metformin alone . This 24 week study measure improvement blood sugar treatment .</brief_summary>
	<brief_title>Mitiglinide Combination With Metformin vs. Metformin Alone Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , parallel group study design evaluate efficacy safety mitiglinide combination metformin patient T2DM less adequately controlled metformin alone . Patients receive metformin alone T2DM randomize equally one three treatment group .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Mitiglinide</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>type 2 diabetes diagnose least 6 month stable metformin usage least 4 month HbA1c 7.5 % 10.5 % inclusive severe diabetic complication chronic insulin use use oral diabetic agent within 12 week acute chronic condition , exclude diabetes , could compromise end point evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>